METHODS
The details of the programme have been reported previously7). Briefly, each diabetic registrant is assigned a Diabetes Control Programme number after a prescription form signed by the registrant's physician is received. The information contained in the form include sex, date of birth, year of onset of diabetes, type of therapy (diet, oral hypoglycemic agents, insulin or insulin plus oral agents), and the kind of hypoglycemic medications. All these data are stored in computer tapes.
For this study, it is assumed that every diabetic person applied for these benefits and that the physician's diagnosis is correct7). The incidence cases are the newly diagnosed cases registered for that year (residents for three or more months before diagnosis that year). Prevalence cases are the registrants for that particular year. Four census years (1966, 1971, 1976 and 1981) provied population figures. The population figures for the intercensal years are interpolated.
Itemized costs on the different components (oral hypoglycemic agents, insulin, and urine testing materials) of the programme are available only from 1978 on.
RESULTS

Prevalence
The prevalence rates of diabetes in PEI from 1966 to 1980 are shown in Table  1 . There was a steady increase in the prevalence rate, from 0.89% in 1966 to 1.94% in 1980. The prevalence rate was higher in women than in men (1977: 1.64% vs. 1.42% and 1980: 2.00% vs. 1.88%). Table 2 shows the age of onset of Table 3 shows the majority of the patients had their disorder for less than ten years, with 4% having diabetes for over than twenty-five years.
I ncidence
The incidence rates of diabetes in PEI were 1.89/1000 in 1977, 2.53/1000 in 1978, 2.33/1000 in 1979, and 2.12/1000 in 1980. in the < 9 year age groups.
Patterns of therapy Talbe 5 shows that the proportion of diabetic patients treated with diet alone was 14.5% in 1977 and increased to 22.4% in 1980. Concurrently, the proportion of patients treated with oral hypoglycemic agents decreased from 52.7% in 1977 to 43.6% in 1980. The proportion of diabetics on insulin remained unchanged. As reported previously by us, the most frequently used oral hypoglycemic agent was chlorpropamide. The most frequently used insulin are intermediate acting insulin by itself or in combination with short acting insulin. In 1979, 13.1% of the insulin requiring patients were on split dose while in 1980 this increased to 14.9%. 
Cost
The budget for providing the hypoglycemic medications and urine testing materials is shown in Table 6 . The cost for insulin has increased whereas those for the oral hypoglycemic agents and urine testing materials have decreased.
DISCUSSION
Many methods have been used to estimate prevalence rates of diabetes mellitus : (1) performing various screening tests for diabetes in a sample population8,9) ; (ii) carrying out household surveys10); (iii) selecting a representative sample of physicians and counting the number of diabetics in their practice"); (iv) determining rates from registers3,5) ; (v) estimating the number of diabetic patients by the number of prescriptions written 12>, and (vi) counting the number of diabetic patients attending hospitals and clinics in a community 12). In PEI, the drug programme is an informal register and we have previously ascertained that >99% of diabetics were registered7). The criteria for diagnosis are believed to be those proposed by Fajans and Cohn14). Although these criteria are not accepted by all, we feel that a physician's diagnosis is more accurate than that of a lay person's as is used in household surveys. Based on the above, the preva lence rate of diabetes has gradually increased from 0.89% in 1966 to 1.94% in 1980. These rates are comparable with those reported in most western nations15) and this is not surprising as most PEI residents are of British origin 16).
Our data support the National Commission on Diabetes' claim that the prevalence of diabetes in the U.S. is increasing") and corroborate those reported in Japan18) and Germany1). In PEI, this is due to a marked increase in the number of diabetics compared with a relatively small increase in the total population. The increase was seen in most age groups, especially in the older age groups 7), suggesting that as the population ages, more people develop diabetes. It is also possible that detection of diabetes is facilitated by the availability of automated systems to measure serum glucose17).
In PEI, the prevalence of diabetes is low in the <9 year age group and increases steadily with age, with the highest prevalence rate in the >80 year age group. When the diabetic patients are classified according to their age of onset, most had onset of their disorder after the age of 40 year, corroborating findings reported by others 13,18,19) Most diabetics have their disorder for less than ten years. Unlike previous studies, 4% of the diabetics in PEI have had their disorder for >25 years, implying that diabetics are surviving longer 20).
The incidence of diabetes in PEI is similar to that reported by others in Western nations", 17,21), with a higher incidence in women. The highest incidence rates were in the older age groups and in our study, they are higher than those reported in Minnesota13), Denmark 22) and Israel 23) .
The proportion of diabetics on diet therapy alone increased from 14.5% in 1977 to 22.4% in 1980, whereas those on oral hypoglycemic agents decreased from 52.7% in 1977 to 43.6% is 1980. This may reflect the emphasis on dietary therapy placed by physicians. The proportion of patients on insulin remained unchanged.
Several factors contribute to the low cost of providing oral hypoglycemic agents to diabetics in PEI. These include (i) bulk buying allowing cheaper shipping costs and permitting purchases at wholesale prices ; (ii) generic substitu tion giving substantial savings as there is a sixfold difference in price between the least and the most expensive brand of chlorpropamide, and (iii) issuing ninety day supplies, thereby reducing handling costs. Finally, we also note that patient compliance was not always 100%, for some patients made a three month supply last a year.
Compared with the cost of oral agents, the cost of insulin is relatively high. This may be partially due to the patients obtaining their insulin supplies from retail pharmacies which in turn bill the Diabetes Control Programme. Another reason may be the lack of competition in insulin sales for until recently, only one company sold insulin in Canada.
The cost of urine testing materials is decreasing. This may be due to the greater emphasis placed on self-monitoring of blood glucose as the way of monitoring diabetes control, resulting in lesser use of urine testing.
